Africa’s vaccine cloning gamble

Africa’s vaccine cloning gamble

Less than a year after the world started putting COVID vaccines into people's arms, most regions have immunized at least half their populations, but Africa still lags behind. With industrialized nations hoarding jabs and the COVAX facility faltering, barely five percent of the African population is fully vaccinated.

Some enterprising South African scientists are now making a bold bid to change that, with an experiment that could benefit not only Africa's 54 nations and billion people, but the entire world: Afrigen Biologics and Vaccines, a Cape Town-based startup, has developed a plan to reverse-engineer Moderna's mRNA shot and manufacture it for priority distribution on the continent.

How are they going to do it? The ingredients in Moderna's vaccine "recipe" are mostly publicly available — the trick is to figure out what to do with them. It's like having all the ingredients and measurements to bake a cake, but only vague instructions for each step.

Given that the Moderna vaccine was developed with US taxpayer money, lawyers are still figuring out which aspects of the process belong solely to the company. But that may be moot for now: the company says it won't sue, leaving Afrigen apparently in the clear to go ahead.

Cloning an mRNA vaccine would be a huge win for South Africa. It would be the equivalent of the moon landing in terms of accomplishment and prestige for a nation that too often grabs headlines for all the wrong reasons. Moreover, the project is backed and funded by the World Health Organization, so if the code is cracked, the formula would be made available to all as a public good across the whole continent and the wider developing world.

A highly effective yet affordable jab that can be manufactured anywhere could be a game-changer to stop more contagious COVID variants from emerging where the population is still unvaccinated. What's more, the sky's the limit when it comes to mRNA's potential to create vaccines against other diseases endemic to Africa such as Ebola, less infectious but way deadlier than COVID.

But don't get too excited just yet. The startup says it'll take up to a year to reverse-engineer Moderna's jab. Also, getting the formula right is only one piece of the puzzle. Afrigen would then need to figure out how to mass-produce, store, and deliver the vaccine around a continent with often poor infrastructure, not to mention getting raw materials at a moment when global supply chains are already stretched thin.

There's a political angle too. In the US, the Biden administration wants Moderna to sell more vaccines to COVAX at cost, and is facing growing criticism for treating the company with kid gloves after ignoring Biden's call to boost production for low-income countries despite Uncle Sam being Moderna's research sugar daddy.

Meanwhile, public health advocates are urging the National Institutes of Health to force Moderna to give up its secret sauce, and calling out the US government for paying lip service to waiving patents and global vaccine equity while not pushing the drugmakers harder to share their tech or prioritize supply for countries with low vaccination rates.

Technically, the Biden administration has some leverage because the White House bankrolled Moderna's vaccine research through the NIH and Operation Warp Speed. But twisting Moderna's arm would be a hard sell for the US government, traditionally reticent to meddle with Big Pharma and with little to gain (politically at home) from vaccinating other countries.

Moderna, for its part, says that right now it's better for the company to expand production itself than to share its tech because scaling up production in Africa will take too long. More broadly, it's also playing a longer game of aiming to dominate the post-COVID mRNA manufacturing landscape along with Pfizer.

No one knows if reverse-engineering mRNA COVID vaccines will work, but then again no one's tried before. Still, the upshot is that there's a huge opportunity despite uncertainty about the science, the business of producing the jab, and the politics behind it all.

Colorful graphic with a woman wearing a red top in the foreground and blue background with two individuals looking on

As the private sector innovates aid and financing, seeking holistic solutions to neighborhood challenges is the cornerstone of the approach.

Businesses, which rely on healthy communities for their own prosperity, must play a big part in driving solutions.

See why.

Abortion rights and anti-abortion demonstrators hold signs outside the U.S. Supreme Court while the court holds a hearing on a Mississippi abortion ban, in Washington, D.C., on Wednesday, December 1, 2021.

On Wednesday the Supreme Court began hearing arguments on an issue that has had Americans fighting — and in some cases killing — each other for 50 years: abortion.

The court must decide whether a recent Mississippi state law that prohibits abortion after 15 weeks of pregnancy is legal and, more broadly, whether it runs counter to the Roe v Wade Supreme Court decision of 1973.

More Show less
S2 Episode 7: Why biodiversity loss matters to governments and investors

Listen: Are global leaders finally taking needed action on environmental issues? Coming out of the COP26 meeting in Glasgow, we've seen governments agree to a certain set of policies to fight climate change. But that isn't the only urgent environmental issue we face. The twin problem of climate change AND biodiversity loss are a serious threat to not just governments, but also investors.

The latest episode of Living Beyond Borders, a special podcast series from GZERO brought to you by Citi Private Bank, looks at how important biodiversity is to the global economy, and what leaders need to do to prevent further loss. Moderated by Caitlin Dean, Head of the Geostrategy Practice at Eurasia Group, this episode features Anita McBain, Managing Director at Citi Research, heading EMEA ESG Research; Harlin Singh, Global Head of Sustainable Investing at Citi Global Wealth; and Mikaela McQuade, Director of Energy, Climate and Resources at Eurasia Group.

More Show less
The Graphic Truth: Abortion laws around the world

While the debate over fetal rights vs a woman’s right to choose is particularly ferocious in the US, it’s also a divisive issue in many parts of the world, particularly in countries where the Catholic Church holds influence. We take a look at abortion laws globally, as well as countries with the highest and lowest official abortion rates.

A man eats by a newspaper stand that displays a cover story on the preliminary results of the general election in Tegucigalpa, Honduras, November 29, 2021

The small Central American nation of Honduras is in many ways a full blown narco-state. President Juan Orlando Hernandez – who’s governed the country for close to a decade – has been linked to the country’s booming drug trafficking trade. His brother Tony, a former congressman who is buds with Mexican drug lord El-Chapo, was sentenced to life-in prison this year for smuggling cocaine into the US. Narco-trafficking gangs run riot in the country, fueling one of the world’s highest murder rates, while corruption and poverty abound.

More Show less

Will the Taliban be able to maintain control over the entire country of Afghanistan if the ongoing hunger and economic crisis worsens?

Civil disobedience is likely to expand from women's protests to widespread unrest, said journalist Ahmed Rashid, especially if humanitarian aid only reaches the hands of Taliban loyalists and the country’s urban elites.

More Show less
Belgium, Brussels, 2021/12/01. EU Commission President Ursula von der Leyen gives a press conference on the Global Gateway at the EU Commission headquarters.

The EU rivals China’s Belt and Road Initiative. The European Commission has unveiled its Global Gateways plan, which aims to invest €300 billion globally in infrastructure projects by 2027. Indeed, Brussels is positioning its plan as a better alternative to China’s ambitious Belt and Road Initiative. This announcement comes as Beijing has been steadily upping its investment in the Global South, including a pledge this week to supply Africa with an additional 1 billion COVID vaccine doses over the next three years, as well as doling out $10 billion of trade finance to support African exports. But European Commission President Ursula Von der Leyen points to several advantages for the European plan. One, Global Gateway focuses both on physical infrastructure – like fiber-optic cables, transportation, healthcare and clean energy resources – as well as investment in research and education. And unlike Beijing’s plan, which saddles recipient countries with debt, the EU will provide cash “under fair and favorable terms.” Its plan will also include buy-in from Europe’s robust private sector. Beijing has not commented on the development, but the Chinese foreign minister’s visit to Ethiopia on Wednesday was likely intended to signal Beijing’s enduring commitment to the region.

More Show less
Afghan women hold signs as they gather for a women's rights protest march in central Kabul, Afghanistan October 21, 2021.

1 billion: In restricting women from working, the Taliban could cost Afghanistan’s economy $1 billion, according to a UN report. That’s 5 percent of the country’s total GDP. Banning women – who make up 20 percent of the Afghan workforce – from many aspects of social life is risky business as the country faces a humanitarian and economic crisis.

More Show less

Subscribe to GZERO Media's newsletter, Signal


Subscribe to GZERO Media's newsletter: Signal


Subscribe to GZERO Media's newsletter: Signal